Clinical Trial Update: Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET) [Phase 4]

View source ↗

Summary

Clinical trial update investigating the effect of sarilumab on atherosclerotic disease in patients with rheumatoid arthritis, assessed by PET/CT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Rheumatoid Arthritis

Drugs mentioned

• Sarilumab (sarilumab)

Snippet

Sponsor: Instituto de Investigación Marqués de Valdecilla | Conditions: Rheumatoid Arthritis, Atherosclerosis | Phase 4 | Status: UNKNOWN